Compile Data Set for Download or QSAR
maximum 50k data
Found 216 with Last Name = 'otani' and Initial = 'm'
TargetCytochrome P450 3A4(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50351401(CHEMBL1819091)
Affinity DataKi:  0.0220nMAssay Description:Inhibition of CYP3A4 in human liver microsomes pre-incubated for 15 mins by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50351399(CHEMBL1819089)
Affinity DataKi:  0.0260nMAssay Description:Inhibition of CYP3A4 in human liver microsomes pre-incubated for 15 mins by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDipeptidyl peptidase 4(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50351399(CHEMBL1819089)
Affinity DataIC50:  0.340nMAssay Description:Inhibition of DPP4 in human plasma assessed as formation of 7-amino-4-methylcoumarin from glycyl-L-proline 4-methylcoumaryl-7-amide by fluorescence a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDipeptidyl peptidase 4(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM11695((2S)-1-{2-[(3-hydroxyadamantan-1-yl)amino]acetyl}p...)
Affinity DataIC50:  0.580nMAssay Description:Inhibition of DPP4 in human plasma assessed as formation of 7-amino-4-methylcoumarin from glycyl-L-proline 4-methylcoumaryl-7-amide by fluorescence a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMedDrugBank

TargetDipeptidyl peptidase 4(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM16285(2-({6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-di...)
Affinity DataIC50:  1nMAssay Description:Inhibition of DPP4 in human plasma assessed as formation of 7-amino-4-methylcoumarin from glycyl-L-proline 4-methylcoumaryl-7-amide by fluorescence a...More data for this Ligand-Target Pair
TargetDipeptidyl peptidase 4(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50351402(CHEMBL1819090)
Affinity DataIC50:  1.10nMAssay Description:Inhibition of DPP4 in human plasma assessed as formation of 7-amino-4-methylcoumarin from glycyl-L-proline 4-methylcoumaryl-7-amide by fluorescence a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDipeptidyl peptidase 4(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM11162((1R)-3-oxo-3-[3-(trifluoroethyl)-5,6-dihydro[1,2,4...)
Affinity DataIC50:  3.5nMAssay Description:Inhibition of DPP4 in human plasma assessed as formation of 7-amino-4-methylcoumarin from glycyl-L-proline 4-methylcoumaryl-7-amide by fluorescence a...More data for this Ligand-Target Pair
TargetDipeptidyl peptidase 4(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50351401(CHEMBL1819091)
Affinity DataIC50:  26nMAssay Description:Inhibition of DPP4 in human plasma assessed as formation of 7-amino-4-methylcoumarin from glycyl-L-proline 4-methylcoumaryl-7-amide by fluorescence a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDipeptidyl peptidase 4(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50351400(CHEMBL1819092)
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of DPP4 in human plasma assessed as formation of 7-amino-4-methylcoumarin from glycyl-L-proline 4-methylcoumaryl-7-amide by fluorescence a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50351399(CHEMBL1819089)
Affinity DataIC50:  1.60E+3nMAssay Description:Inhibition of CYP3A4More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50351399(CHEMBL1819089)
Affinity DataIC50:  7.50E+3nMAssay Description:Inhibition of CYP2D6More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMuscarinic acetylcholine receptor M1(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50351402(CHEMBL1819090)
Affinity DataIC50: >1.00E+4nMAssay Description:Binding affinity to muscarinic receptor 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMuscarinic acetylcholine receptor M2(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50351402(CHEMBL1819090)
Affinity DataIC50: >1.00E+4nMAssay Description:Binding affinity to muscarinic receptor 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMuscarinic acetylcholine receptor M4(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50351402(CHEMBL1819090)
Affinity DataIC50: >1.00E+4nMAssay Description:Binding affinity to muscarinic receptor 4More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 1A2(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50351399(CHEMBL1819089)
Affinity DataIC50:  1.47E+4nMAssay Description:Inhibition of CYP1A2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50351402(CHEMBL1819090)
Affinity DataIC50:  3.00E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50351402(CHEMBL1819090)
Affinity DataIC50:  3.80E+4nMAssay Description:Inhibition of CYP2D6More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50351402(CHEMBL1819090)
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of CYP3A4 in human liver microsomes pre-incubated for 15 mins by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50351402(CHEMBL1819090)
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of CYP2C19More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50351402(CHEMBL1819090)
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of CYP2C9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C8(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50351402(CHEMBL1819090)
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of CYP2C8More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 1A2(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50351402(CHEMBL1819090)
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of CYP1A2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetXaa-Pro aminopeptidase 2(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50351402(CHEMBL1819090)
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of aminopeptidase PMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProlyl endopeptidase(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50351402(CHEMBL1819090)
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of prolyl oligopeptidaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDipeptidyl peptidase 9(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50351402(CHEMBL1819090)
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of DPP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDipeptidyl peptidase 8(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50351402(CHEMBL1819090)
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of DPP8More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDipeptidyl peptidase 2(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50351402(CHEMBL1819090)
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of DPP2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProlyl endopeptidase FAP(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50351402(CHEMBL1819090)
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of FAPalphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2A6(Homo sapiens (Human))
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50351402(CHEMBL1819090)
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of CYP2A6More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610865(US10626095, Example 646)
Affinity DataEC50:  620nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610866(US10626095, Example 649)
Affinity DataEC50:  2.47E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610868(US10626095, Example 657)
Affinity DataEC50:  1.16E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610869(US10626095, Example 659)
Affinity DataEC50:  810nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610870(US10626095, Example 663)
Affinity DataEC50:  1.25E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610871(US10626095, Example 718)
Affinity DataEC50:  1.51E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610872(US10626095, Example 790)
Affinity DataEC50:  980nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610873(US10626095, Example 807)
Affinity DataEC50:  1.10E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610875(US10626095, Example 931)
Affinity DataEC50:  690nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610876(US10626095, Example 934)
Affinity DataEC50:  510nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610877(US10626095, Example 944)
Affinity DataEC50:  1.01E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610878(US10626095, Example 989)
Affinity DataEC50:  800nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610879(US10626095, Example 1004)
Affinity DataEC50:  1.80E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610880(US10626095, Example 1017)
Affinity DataEC50:  1.00E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610881(US10626095, Example 1018)
Affinity DataEC50:  1.17E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610882(US10626095, Example 1248)
Affinity DataEC50:  3.05E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610883(US10626095, Example 1505)
Affinity DataEC50:  420nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610884(US10626095, Example 1573)
Affinity DataEC50:  1.03E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610885(US10626095, Example 1672)
Affinity DataEC50:  1.29E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610886(US10626095, Example 1676)
Affinity DataEC50:  2.22E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610688(US10626095, Example 1)
Affinity DataEC50:  500nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 216 total ) | Next | Last >>
Jump to: